Wong Hing C's Form 4/A amendment
AmendedHCW Biologics Inc. (HCWB) · filed Oct 7, 2021
- Accession no.
- 0001209191-21-059989
- Filed
- Oct 7, 2021
- Trade date
- Aug 31, 2021
- Filing delay
- 37 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 2, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $23.0K. It was filed 37 days after the trade.
This amendment replaces 0001209191-21-054545 (filed Sep 2, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wong Hing CCIK 0001866258 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2021 | Common Stock | PPurchaseAcquired | +5,830 | $3.94F1 | +$22,970.2 | 15,281,948 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The range of prices for the shares of Common Stock is from $3.91 to $3.97. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
The only purpose of this amendment to the Form 4 filed on September 2, 2021 by the reporting person is to include the purchase of 2,000 additional shares of Common Stock made on August 31, 2021 which was inadvertently not reported in his Form 4.